Allergy medications containing chlorphenamine maleate have been a cornerstone of allergic symptom relief in the UK for decades. Sold widely under brand names such as Piriton, this first-generation antihistamine works by blocking histamine H1 receptors to ease sneezing, itching, runny nose, and watery eyes triggered by allergens including pollen, dust mites, and animal dander. Available over the counter as tablets and syrup, it suits both adults and children. However, its sedative properties and anticholinergic effects mean it is not suitable for everyone. This guide covers how chlorphenamine maleate works, its uses, dosing, side effects, interactions, and when to seek NHS advice.

What Is Chlorphenamine Maleate and How Does It Work?

Chlorphenamine maleate (also known as chlorpheniramine maleate in some international contexts) is the UK-approved name for this first-generation antihistamine, used in the UK for decades as a reliable and widely available allergy medication. It belongs to the alkylamine class of antihistamines and works by competitively blocking histamine H1 receptors throughout the body. When the immune system encounters an allergen — such as pollen, animal dander, or dust mites — it triggers the release of histamine, a chemical mediator responsible for the classic symptoms of allergic reactions, including itching, sneezing, runny nose, and watery eyes. By blocking these receptors, chlorphenamine maleate reduces or prevents these symptoms from occurring.

Unlike second-generation antihistamines such as cetirizine or loratadine, chlorphenamine maleate readily crosses the blood-brain barrier due to its lipophilic nature. This central nervous system penetration is responsible for its well-known sedative properties, which can be both a side effect and, in some clinical contexts, a therapeutic advantage — for example, when itching disrupts sleep. The drug also has mild anticholinergic activity, which contributes to additional effects such as dry mouth and urinary hesitancy.

Chlorophenamine maleate is available over the counter in the UK under various brand names, including Piriton, and is also found as an ingredient in combination cold and flu remedies. It is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and has a well-established safety profile when used as directed. Its relatively rapid onset of action — typically within 30 to 60 minutes of oral administration — makes it a practical choice for managing acute allergic symptoms.

Conditions Chlorphenamine Maleate Is Used to Treat

Chlorphenamine maleate is indicated for a broad range of allergic conditions, making it one of the most versatile allergy medications available without a prescription in the UK. Its primary uses include:

• Allergic rhinitis (hay fever): relieving sneezing, itching, and runny nose (rhinorrhoea) caused by seasonal or perennial allergens. Note that antihistamines have limited effect on nasal congestion (blockage); a separate decongestant or intranasal corticosteroid may be needed for this symptom.

• Urticaria (hives): reducing the itching and wheals associated with allergic skin reactions

• Allergic conjunctivitis: easing eye irritation triggered by allergens

• Insect bites and stings: alleviating localised itching and swelling

• Mild cutaneous allergic reactions (for example, to foods or medicines): providing symptomatic relief from mild skin symptoms such as itching or urticaria. Chlorphenamine maleate is not a substitute for emergency treatment and should not be used for systemic or severe allergic reactions.

In hospital and emergency settings, chlorphenamine maleate may be administered by injection as an adjunct in the management of anaphylaxis — but only to treat cutaneous symptoms (such as itching and urticaria) after life-threatening features have been addressed. In line with Resuscitation Council UK (2021) guidance, adrenaline (epinephrine) is the only first-line treatment for anaphylaxis. Antihistamines are not first-line agents and must never delay or replace adrenaline. Corticosteroids are no longer routinely recommended in the immediate management of anaphylaxis.

Chlorophenamine maleate is also commonly included in combination cold and flu preparations, where it helps to relieve runny nose and sneezing associated with upper respiratory tract infections. However, NICE guidance and NHS advice generally caution against the routine use of combination cold remedies, particularly in children, as the evidence for their effectiveness is limited and the risk of inadvertent double-dosing with multiple ingredients is a patient safety concern.

Recommended Doses and How to Take It Safely

Chlorphenamine maleate is available in tablet form (typically 4 mg) and as a syrup (2 mg per 5 ml), making it suitable for both adults and children. Dosing recommendations vary by age, and it is essential to follow the product's patient information leaflet (PIL) or the advice of a pharmacist or GP. Age licences and maximum doses vary between brands — always check the specific PIL or Summary of Product Characteristics (SmPC) for the product you are using.

Standard adult dosing (aged 12 and over):

• 4 mg every 4 to 6 hours as needed

• Maximum dose: 24 mg in 24 hours

Children's dosing (syrup formulation):

• Ages 6–12 years: 2 mg every 4 to 6 hours (maximum 12 mg in 24 hours)

• Ages 2–5 years: 1 mg every 4 to 6 hours (maximum 6 mg in 24 hours)

• Ages 1–2 years: 1 mg twice daily — only under medical supervision and depending on the specific product licence

• Not recommended for children under 1 year without specialist medical advice

Some over-the-counter syrup products are licensed from 1 year of age; however, use in children under 2 years should always be discussed with a GP or pharmacist first, as product licences differ.

Chlorophenamine maleate can be taken with or without food, though taking it with food or milk may help reduce the likelihood of stomach upset. Because of its sedative properties, it is advisable to take it in the evening if daytime drowsiness is a concern. This medicine may cause drowsiness. If affected, do not drive or operate machinery.

It is important not to exceed the stated dose or take chlorphenamine maleate alongside other products containing antihistamines, as this increases the risk of adverse effects. If symptoms persist beyond a few days or worsen, patients should seek advice from a pharmacist or GP rather than continuing self-medication indefinitely.

Common Side Effects and Important Precautions

As a first-generation antihistamine, chlorphenamine maleate is associated with a number of side effects, the most frequently reported of which is drowsiness. This occurs because the drug crosses the blood-brain barrier and exerts a sedative effect on the central nervous system. While this can be beneficial for patients whose allergy symptoms disrupt sleep, it is an important consideration for those who need to remain alert during the day.

Other commonly reported side effects include:

• Dry mouth, nose, and throat (due to anticholinergic activity)

• Blurred vision

• Urinary retention or difficulty passing urine

• Constipation

• Dizziness or impaired coordination

• Headache

• Nausea or gastrointestinal discomfort

In rare cases, paradoxical excitability — particularly in children — has been reported, manifesting as restlessness, irritability, or insomnia. This is more likely at higher doses.

Several important precautions apply to the use of chlorphenamine maleate:

• Elderly patients are more susceptible to anticholinergic and sedative side effects, including confusion, urinary retention, and an increased risk of falls. Chlorphenamine maleate should be used with particular caution in this age group.

• Patients with angle-closure glaucoma, enlarged prostate, epilepsy, or liver disease should seek medical advice before use.

• Alcohol significantly potentiates the sedative effects and should be avoided during treatment.

• Chlorphenamine maleate should be used with caution in patients with asthma or chronic obstructive pulmonary disease (COPD), as its drying effect on secretions may worsen respiratory symptoms.

If any unusual or severe side effects occur, patients should stop taking the medication and consult a healthcare professional promptly.

Reporting side effects: If you experience a suspected side effect, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting helps the MHRA monitor the ongoing safety of medicines.

Drug Interactions and Who Should Avoid This Antihistamine

Chlorphenamine maleate has a number of clinically significant drug interactions that patients and healthcare professionals should be aware of. Because of its sedative and anticholinergic properties, it can interact with a wide range of medications:

• Central nervous system (CNS) depressants: Combining chlorphenamine with sedatives, hypnotics, anxiolytics, opioid analgesics, or alcohol can cause additive sedation and increase the risk of respiratory depression.

• Monoamine oxidase inhibitors (MAOIs): Concurrent use is contraindicated, as it may intensify and prolong the anticholinergic effects of chlorphenamine. A washout period of at least 14 days after stopping an MAOI is recommended before starting chlorphenamine.

• Tricyclic antidepressants: These also have anticholinergic properties, and combining them with chlorphenamine increases the risk of side effects such as urinary retention, constipation, and confusion.

• Other antimuscarinic medicines (for example, oxybutynin, hyoscine, or certain bladder medications): Additive anticholinergic effects may occur, increasing the risk of dry mouth, urinary retention, and confusion.

• Phenytoin: Chlorphenamine may inhibit the metabolism of phenytoin, potentially leading to elevated plasma levels and toxicity.

Certain patient groups should avoid chlorphenamine maleate entirely or use it only under medical supervision:

• Patients taking MAOIs or who have taken them within the past 14 days

• Those with acute angle-closure glaucoma

• Patients with symptomatic prostatic hypertrophy or bladder neck obstruction

• Individuals with a known hypersensitivity to chlorphenamine or related antihistamines

Pregnancy and breastfeeding: Chlorphenamine maleate has a long history of clinical use in the UK and is generally considered acceptable when treatment is needed during pregnancy or breastfeeding, based on available evidence. However, it should only be used if the benefit outweighs any potential risk. Pregnant women or those who are breastfeeding should discuss use with their GP or midwife before taking this medicine. If taken whilst breastfeeding, monitor the infant for signs of drowsiness. For further information, refer to the UK Teratology Information Service (UKTIS/BUMPS) and NHS guidance on chlorphenamine in pregnancy.

Always inform your pharmacist or GP of all medications — including herbal remedies and supplements — before starting chlorphenamine maleate.

Alternatives and When to Seek NHS or GP Advice

For patients who find the sedative effects of chlorphenamine maleate problematic, second-generation antihistamines offer a non-drowsy alternative. These include:

• Cetirizine hydrochloride (e.g., Zirtek) — available over the counter

• Loratadine (e.g., Clarityn) — available over the counter

• Fexofenadine (e.g., Telfast) — available over the counter or as a prescription medicine depending on strength

• Bilastine (e.g., Ilaxten) — prescription-only in the UK

Availability varies: some second-generation antihistamines can be purchased from a pharmacy without a prescription, whilst others require a GP prescription. Check with your pharmacist if you are unsure.

These newer antihistamines are less likely to cross the blood-brain barrier and are generally preferred for daytime use. NICE Clinical Knowledge Summaries (CKS) and NHS guidance support their use as first-line treatment for allergic rhinitis in most adults and older children. However, chlorphenamine maleate remains a valid option, particularly when a sedating effect is desirable or when cost is a consideration.

For patients with more persistent or severe allergic conditions, additional treatments may be appropriate:

• Intranasal corticosteroids (such as beclometasone or fluticasone nasal sprays) are recommended by NICE as the most effective treatment for moderate-to-severe allergic rhinitis and are particularly helpful for nasal congestion.

• Intranasal antihistamines (such as azelastine nasal spray) or combination intranasal sprays (such as azelastine with fluticasone) may be considered where both antihistamine and corticosteroid effects are needed.

• Allergen immunotherapy (desensitisation) may be considered for selected patients with confirmed allergic rhinitis or insect venom allergy, in line with BSACI guidance.

Patients should seek advice from their GP or contact NHS 111 if:

• Allergy symptoms are severe, persistent, or significantly affecting quality of life

• Over-the-counter antihistamines are not providing adequate relief

• There is any suspicion of anaphylaxis — characterised by throat swelling, difficulty breathing, or a sudden drop in blood pressure — in which case call 999 immediately

• Symptoms suggest a new or worsening underlying condition

• The patient is pregnant, breastfeeding, or managing a complex medical history

Regular review with a GP or allergy specialist ensures that allergy management remains safe, effective, and tailored to the individual's needs.

Frequently Asked Questions